Cellectar Biosciences Inc Financial Flexibility Index
Cellectar Biosciences Inc financial flexibility index. Cellectar Biosciences Inc (CLRB) has a Financial Flexibility Index of -0.86x as of December 2025. Free cash flow of $-4.34 Million (operating CF $-4.34 Million minus capex $5.88K) represents -1% of total liabilities ($5.06 Million). See Cellectar Biosciences Inc (CLRB) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Cellectar Biosciences Inc (2004–2025)
Financial flexibility index of Cellectar Biosciences Inc from 2004 to 2025. Historical Financial Flexibility Index trend for Cellectar Biosciences Inc across 22 annual periods. Check Cellectar Biosciences Inc (CLRB) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Cellectar Biosciences Inc Financial Flexibility Index by Year (2004–2025)
Cellectar Biosciences Inc financial flexibility index by year from 2004 to 2025. Year-by-year free cash flow to debt coverage for Cellectar Biosciences Inc. For the full cash flow conversion analysis, see cash efficiency ratio of Cellectar Biosciences Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.57x | $-23.11 Million | $-23.12 Million | $5.06 Million | ▼ -7.6% |
| 2024 | -4.25x | $-47.48 Million | $-47.58 Million | $11.18 Million | ▼ -248.4% |
| 2023 | -1.22x | $-31.51 Million | $-32.38 Million | $25.85 Million | ▲ +41.2% |
| 2022 | -2.07x | $-25.00 Million | $-25.22 Million | $12.05 Million | ▲ +61.6% |
| 2021 | -5.40x | $-22.43 Million | $-22.57 Million | $4.16 Million | ▼ -50.3% |
| 2020 | -3.59x | $-13.87 Million | $-13.93 Million | $3.86 Million | ▲ +1.8% |
| 2019 | -3.66x | $-11.67 Million | $-11.69 Million | $3.19 Million | ▲ +40.7% |
| 2018 | -6.17x | $-11.06 Million | $-11.44 Million | $1.79 Million | ▼ -22.3% |
| 2017 | -5.04x | $-10.67 Million | $-11.02 Million | $2.12 Million | ▼ -9.6% |
| 2016 | -4.60x | $-8.21 Million | $-8.28 Million | $1.78 Million | ▼ -235.5% |
| 2015 | -1.37x | $-8.15 Million | $-8.21 Million | $5.95 Million | ▲ +58.4% |
| 2014 | -3.30x | $-8.81 Million | $-8.84 Million | $2.67 Million | ▼ -87.2% |
| 2013 | -1.76x | $-9.01 Million | $-9.15 Million | $5.12 Million | ▲ +64.2% |
| 2012 | -4.92x | $-6.49 Million | $-6.59 Million | $1.32 Million | ▲ +9.1% |
| 2011 | -5.41x | $-5.85 Million | $-5.97 Million | $1.08 Million | ▲ +13.1% |
| 2010 | -6.22x | $-7.80 Million | $-7.80 Million | $1.25 Million | ▼ -2003.5% |
| 2009 | -0.30x | $-10.60 Million | $-10.62 Million | $35.83 Million | ▲ +87.9% |
| 2008 | -2.45x | $-17.28 Million | $-17.33 Million | $7.05 Million | ▼ -209.6% |
| 2007 | -0.79x | $-13.44 Million | $-13.47 Million | $16.98 Million | ▲ +83.9% |
| 2006 | -4.92x | $-6.46 Million | $-6.47 Million | $1.31 Million | ▲ +55.0% |
| 2005 | -10.93x | $-2.37 Million | $-2.40 Million | $217.16K | ▼ -12417.6% |
| 2004 | -0.09x | $-389.17K | $-389.18K | $4.46 Million | — |